Predictors of treatment response in chronic hepatitis B.
about
Comparison of three luminescent immunoassays for hepatitis B virus surface antigen quantification during the natural history of chronic hepatitis B virus infection.Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.Analysis of mutations in the S gene of hepatitis B virus strains in patients with chronic infection by online bioinformatics tools.Efficacy of peginterferon α-2a and predictors of response in HBeAg-negative, genotype D-naive patientsSerum proteins in chronic hepatitis B patients treated with peginterferon alfa-2b.Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapyHepatitis B virus serology to predict antiviral response in chronic hepatitis B.Current developments in nucleoside/nucleotide analogues for hepatitis B.Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B.Analysis of HBsAg using high-sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assays.Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E.Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.Who will have the best response to entecavir?
P2860
Q34592952-AF7B7091-F5C2-47D0-A6BA-C587F7F7530DQ35739079-DA67A424-0DC5-4D52-941B-560146B731EDQ36197335-207E8B21-7C31-4946-9A0B-497FD768998EQ36506360-C6060B7C-1C9A-436B-954E-CEDE5102B0C1Q37072918-D18AB8C3-947A-4457-9268-749A60E3BA7CQ37102450-344E60F7-B90B-4414-BB30-228532E5F73AQ37632321-D0316BEF-0B6F-402D-B93B-35504D91F818Q37966704-2F44C5F4-118B-40B5-BBD4-65CD4913F8EDQ38208628-534733AC-7EE6-423D-AF0A-0BAAF83628D8Q38268743-EA1DFDD3-E71F-4011-9EBD-CFC216F761C4Q40051443-F225FC3E-CEBE-4FDC-A2A4-88390145D1AAQ42199429-27C03703-BB57-4B18-818A-962B498364E4Q42279126-4DF6BD2A-A70C-4821-9D12-1357ADD19D15Q44288703-1D4C7411-146A-4E45-97B6-DFA37C23F6D8
P2860
Predictors of treatment response in chronic hepatitis B.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Predictors of treatment response in chronic hepatitis B.
@en
Predictors of treatment response in chronic hepatitis B.
@nl
type
label
Predictors of treatment response in chronic hepatitis B.
@en
Predictors of treatment response in chronic hepatitis B.
@nl
prefLabel
Predictors of treatment response in chronic hepatitis B.
@en
Predictors of treatment response in chronic hepatitis B.
@nl
P2860
P1433
P1476
Predictors of treatment response in chronic hepatitis B.
@en
P2093
Grace L-H Wong
Henry L-Y Chan
P2860
P304
P356
10.2165/11319850-000000000-00000
P577
2009-11-01T00:00:00Z
P6179
1026188609